Lexicon Pharmaceuticals Inc. (LXRX) NASDAQ
$2.39 0.20 (9.13%)
Market Cap: $539.26M
As of 03/28/24 03:59 PM EDT. Market closed.
Lexicon Pharmaceuticals Inc. (LXRX)
NASDAQ
$2.39
0.20 (9.13%)
Market Cap: $539.26M
As of 03/28/24 03:59 PM EDT. Market closed.
corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the ... read more
corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. we have integrated a series of recombinant dna and chemistry technologies into a systematic drug discovery and development process. our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. a diverse pipeline of targeted therapies our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indicatio read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Artal International S.C.A. | Director | Mar 13, 2024 | Option Exercise | $108.50 | 1,150,922 | 124,875,037 | 1,150,922 | Mar 13, 2024, 09:22 PM |
Alexander Kristen | VP, Finance and Accounting | Feb 28, 2024 | Option Exercise | $2.62 | 11,793 | 30,898 | 47,800 | Feb 29, 2024, 04:33 PM |
WADE JEFFREY L | President and CFO | Feb 28, 2024 | Option Exercise | $2.62 | 37,691 | 98,750 | 324,214 | Feb 29, 2024, 04:32 PM |
McDermott Wendy | VP, Human Resources | Feb 28, 2024 | Option Exercise | $2.62 | 22,425 | 58,753 | 52,694 | Feb 29, 2024, 04:31 PM |
MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2024 | Option Exercise | $2.62 | 24,408 | 63,949 | 255,724 | Feb 29, 2024, 04:30 PM |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2024 | Option Exercise | $2.62 | 24,353 | 63,805 | 162,672 | Feb 29, 2024, 04:29 PM |
Granowitz Craig B | SVP, Chief Medical Officer | Feb 28, 2024 | Option Exercise | $2.62 | 31,265 | 81,914 | 47,626 | Feb 29, 2024, 04:28 PM |
Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2024 | Option Exercise | $2.62 | 25,604 | 67,082 | 177,497 | Feb 29, 2024, 04:27 PM |
COATS LONNEL | Chief Executive Officer | Feb 28, 2024 | Option Exercise | $2.62 | 61,371 | 160,792 | 1,098,068 | Feb 29, 2024, 04:26 PM |
COATS LONNEL | Chief Executive Officer | Nov 16, 2023 | Buy | $1.05 | 90,000 | 94,797 | 914,359 | Nov 17, 2023, 04:55 PM |
Amouyal Philippe | Director | Nov 13, 2023 | Buy | $1.01 | 200,000 | 201,520 | 240,332 | Nov 14, 2023, 04:12 PM |
COATS LONNEL | Chief Executive Officer | Nov 10, 2023 | Buy | $1.01 | 10,000 | 10,100 | 824,359 | Nov 13, 2023, 05:31 PM |
DEBBANE RAYMOND | Director | Oct 12, 2023 | Buy | $1.03 | 148,820 | 153,805 | 1,340,847 | Oct 12, 2023, 04:01 PM |
DEBBANE RAYMOND | Director | Oct 11, 2023 | Buy | $1.08 | 342,874 | 370,784 | 1,192,027 | Oct 12, 2023, 04:01 PM |
DEBBANE RAYMOND | Director | Oct 10, 2023 | Buy | $1.14 | 508,306 | 579,367 | 849,153 | Oct 12, 2023, 04:01 PM |
WADE JEFFREY L | President and CFO | Sep 14, 2023 | Buy | $1.38 | 10,000 | 13,800 | 264,341 | Sep 14, 2023, 05:05 PM |
McDermott Wendy | VP, Human Resources | Aug 04, 2023 | Buy | $1.84 | 6,000 | 11,040 | 28,478 | Aug 07, 2023, 04:13 PM |
COATS LONNEL | Chief Executive Officer | Jun 29, 2023 | Buy | $2.16 | 10,000 | 21,600 | 814,359 | Jun 29, 2023, 04:13 PM |
McDermott Wendy | VP, Human Resources | Jun 23, 2023 | Buy | $2.43 | 10,000 | 24,300 | 22,478 | Jun 27, 2023, 04:22 PM |
COATS LONNEL | Chief Executive Officer | Jun 26, 2023 | Buy | $2.18 | 10,000 | 21,792 | 804,359 | Jun 26, 2023, 04:04 PM |
COATS LONNEL | Chief Executive Officer | Jun 23, 2023 | Buy | $2.49 | 10,000 | 24,950 | 794,359 | Jun 26, 2023, 04:04 PM |
COATS LONNEL | Chief Executive Officer | Jun 22, 2023 | Buy | $2.31 | 40,000 | 92,400 | 784,359 | Jun 22, 2023, 04:01 PM |
WADE JEFFREY L | President and CFO | Jun 20, 2023 | Buy | $2.33 | 12,000 | 28,000 | 254,341 | Jun 20, 2023, 04:10 PM |
Artal International S.C.A. | Director | Jun 05, 2023 | Buy | $2.60 | 27,775,050 | 72,215,127 | 78,634,381 | Jun 05, 2023, 04:46 PM |
Alexander Kristen | VP, Finance and Accounting | Feb 28, 2023 | Option Exercise | $2.17 | 5,330 | 11,566 | 30,350 | Mar 01, 2023, 04:56 PM |
Seth Kiernan | VP, Chief Commercial Officer | Feb 28, 2023 | Option Exercise | $2.17 | 11,813 | 25,634 | 53,136 | Mar 01, 2023, 04:55 PM |
McDermott Wendy | VP, Human Resources | Feb 28, 2023 | Option Exercise | $2.17 | 6,465 | 14,029 | 12,478 | Mar 01, 2023, 04:54 PM |
MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2023 | Option Exercise | $2.17 | 20,946 | 45,453 | 212,586 | Mar 01, 2023, 04:53 PM |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2023 | Option Exercise | $2.17 | 19,118 | 41,486 | 119,625 | Mar 01, 2023, 04:51 PM |
Granowitz Craig B | SVP, Chief Medical Officer | Feb 28, 2023 | Option Exercise | $2.17 | 12,732 | 27,628 | 15,185 | Mar 01, 2023, 04:50 PM |
Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2023 | Option Exercise | $2.17 | 20,537 | 44,565 | 134,798 | Mar 01, 2023, 04:49 PM |
WADE JEFFREY L | President and CFO | Feb 28, 2023 | Option Exercise | $2.17 | 30,255 | 65,653 | 242,341 | Mar 01, 2023, 04:48 PM |
COATS LONNEL | Chief Executive Officer | Feb 28, 2023 | Option Exercise | $2.17 | 50,971 | 110,607 | 744,359 | Mar 01, 2023, 04:46 PM |
Invus US Partners LLC | Director | Aug 05, 2022 | Buy | $2.50 | 147,390 | 368,475 | 5,451,204 | Aug 09, 2022, 04:48 PM |
Artal International S.C.A. | Director | Aug 05, 2022 | Buy | $2.50 | 2,426,070 | 6,065,175 | 50,859,331 | Aug 09, 2022, 04:46 PM |
Artal International S.C.A. | Director | Aug 01, 2022 | Buy | $2.50 | 16,173,800 | 40,434,500 | 48,433,261 | Aug 01, 2022, 04:15 PM |
Invus US Partners LLC | Director | Aug 01, 2022 | Buy | $2.50 | 982,600 | 2,456,500 | 5,303,814 | Aug 01, 2022, 04:15 PM |
DEBBANE RAYMOND | Director | Aug 01, 2022 | Buy | $2.50 | 982,600 | 2,456,500 | 5,303,814 | Aug 01, 2022, 04:13 PM |
Alexander Kristen | VP, Finance and Accounting | Feb 28, 2022 | Option Exercise | $2.85 | 3,337 | 9,510 | 16,963 | Feb 28, 2022, 07:18 PM |
Seth Kiernan | VP, Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $2.85 | 8,261 | 23,544 | 21,867 | Feb 28, 2022, 07:17 PM |
MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2022 | Option Exercise | $2.85 | 19,756 | 56,305 | 175,589 | Feb 28, 2022, 07:16 PM |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2022 | Option Exercise | $2.85 | 13,241 | 37,737 | 85,857 | Feb 28, 2022, 07:15 PM |
Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2022 | Option Exercise | $2.85 | 15,059 | 42,918 | 99,458 | Feb 28, 2022, 07:13 PM |
WADE JEFFREY L | President and CFO | Feb 28, 2022 | Option Exercise | $2.85 | 25,773 | 73,453 | 193,680 | Feb 28, 2022, 07:12 PM |
COATS LONNEL | Chief Executive Officer | Feb 28, 2022 | Option Exercise | $2.85 | 48,053 | 136,951 | 586,003 | Feb 28, 2022, 07:11 PM |
Tessmer James F | VP, Finance & Accounting | Mar 15, 2021 | Option Exercise | $3.31 | 12,000 | 39,720 | 83,766 | Mar 16, 2021, 07:45 PM |
Tessmer James F | VP, Finance & Accounting | Mar 15, 2021 | Sale | $6.92 | 22,912 | 158,440 | 71,766 | Mar 16, 2021, 07:45 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2021 | Option Exercise | $7.19 | 26,584 | 191,139 | 157,020 | Mar 02, 2021, 05:01 PM |
TYLE PRAVEEN | EVP, R&D | Feb 28, 2021 | Option Exercise | $7.19 | 16,560 | 119,066 | 120,791 | Mar 02, 2021, 12:00 AM |
Crum Brian T | VP, General Counsel & Secr. | Feb 28, 2021 | Option Exercise | $7.19 | 14,860 | 106,843 | 73,637 | Mar 02, 2021, 12:00 AM |
MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2021 | Option Exercise | $7.19 | 20,413 | 146,769 | 140,695 | Mar 02, 2021, 12:00 AM |
COATS LONNEL | President and CEO | Feb 28, 2021 | Option Exercise | $7.19 | 55,038 | 395,723 | 436,713 | Mar 02, 2021, 12:00 AM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2021 | Option Exercise | $7.19 | 10,765 | 77,400 | 82,678 | Mar 02, 2021, 12:00 AM |
Artal International S.C.A. | Director | Dec 16, 2020 | Buy | $3.20 | 10,937,500 | 35,000,001 | 32,259,461 | Dec 17, 2020, 02:43 PM |
Invus Public Equities, L.P. | Director | Dec 16, 2020 | Buy | $3.20 | 10,937,500 | 35,000,001 | 32,259,461 | Dec 17, 2020, 02:39 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Apr 22, 2020 | Option Exercise | $1.96 | 9,651 | 18,916 | 115,495 | Apr 24, 2020, 05:24 PM |
TYLE PRAVEEN | EVP, R&D | Apr 22, 2020 | Option Exercise | $1.96 | 4,844 | 9,494 | 69,344 | Apr 24, 2020, 05:20 PM |
Tessmer James F | VP, Finance & Accounting | Apr 22, 2020 | Option Exercise | $1.96 | 3,997 | 7,834 | 65,127 | Apr 24, 2020, 05:15 PM |
Santini Alexander A | EVP and CCO | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 55,584 | Apr 24, 2020, 05:12 PM |
MAIN ALAN J | EVP, Commercial Supply Ops | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 104,640 | Apr 24, 2020, 05:08 PM |
Crum Brian T | VP, General Counsel & Secr. | Apr 22, 2020 | Option Exercise | $1.96 | 6,398 | 12,540 | 49,732 | Apr 24, 2020, 05:05 PM |
Lapuerta Pablo | EVP and CMO | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 85,719 | Apr 24, 2020, 05:02 PM |
Santini Alexander A | EVP and CCO | Feb 28, 2020 | Option Exercise | $2.77 | 12,420 | 34,403 | 42,504 | Mar 03, 2020, 04:16 PM |
Lapuerta Pablo | EVP and CMO | Feb 28, 2020 | Option Exercise | $2.77 | 13,305 | 36,855 | 72,639 | Mar 03, 2020, 04:15 PM |
MAIN ALAN J | EVP, Commercial Supply Ops | Feb 28, 2020 | Option Exercise | $2.77 | 12,759 | 35,342 | 91,560 | Mar 03, 2020, 04:13 PM |
Crum Brian T | VP, General Counsel & Secr. | Feb 28, 2020 | Option Exercise | $2.77 | 6,940 | 19,224 | 36,237 | Mar 03, 2020, 04:12 PM |
COATS LONNEL | President and CEO | Feb 28, 2020 | Option Exercise | $2.77 | 45,320 | 125,536 | 298,866 | Mar 03, 2020, 04:11 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2020 | Option Exercise | $2.77 | 16,025 | 44,389 | 98,621 | Mar 03, 2020, 12:00 AM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2020 | Option Exercise | $2.77 | 3,902 | 10,809 | 55,862 | Mar 03, 2020, 12:00 AM |
COATS LONNEL | President and CEO | Sep 18, 2019 | Buy | $3.10 | 50,000 | 155,000 | 227,539 | Sep 19, 2019, 04:28 PM |
Santini Alexander A | EVP and CCO | Sep 18, 2019 | Buy | $3.36 | 4,500 | 15,115 | 18,661 | Sep 19, 2019, 04:26 PM |
COATS LONNEL | President and CEO | Sep 17, 2019 | Buy | $3.13 | 50,000 | 156,403 | 177,539 | Sep 18, 2019, 04:39 PM |
DEBBANE RAYMOND | Director | Sep 16, 2019 | Buy | $2.72 | 93,773 | 254,785 | 313,417 | Sep 17, 2019, 05:36 PM |
DEBBANE RAYMOND | Director | Sep 13, 2019 | Buy | $2.46 | 9,269 | 22,806 | 219,644 | Sep 17, 2019, 05:36 PM |
DEBBANE RAYMOND | Director | Sep 13, 2019 | Buy | $2.40 | 197,473 | 474,760 | 210,375 | Sep 17, 2019, 05:33 PM |
SOBECKI CHRISTOPHER J | Director | Sep 16, 2019 | Buy | $2.55 | 25,000 | 63,718 | 137,293 | Sep 17, 2019, 05:27 PM |
SOBECKI CHRISTOPHER J | Director | Sep 13, 2019 | Buy | $2.41 | 99,249 | 238,750 | 112,293 | Sep 17, 2019, 05:23 PM |
COATS LONNEL | President and CEO | Aug 19, 2019 | Buy | $1.40 | 3,000 | 4,194 | 127,539 | Aug 20, 2019, 05:02 PM |
COATS LONNEL | President and CEO | Aug 16, 2019 | Buy | $1.35 | 37,000 | 49,835 | 124,539 | Aug 20, 2019, 05:02 PM |
Tessmer James F | VP, Finance & Accounting | Aug 02, 2019 | Buy | $1.14 | 10,000 | 11,400 | 43,368 | Aug 02, 2019, 04:15 PM |
BARKER SAM L | Director | Aug 02, 2019 | Buy | $1.17 | 24,000 | 28,200 | 52,187 | Aug 02, 2019, 04:12 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2019 | Option Exercise | $5.51 | 8,639 | 47,601 | 72,508 | Mar 01, 2019, 05:20 PM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2019 | Option Exercise | $5.51 | 2,501 | 13,781 | 33,368 | Mar 01, 2019, 05:18 PM |
Santini Alexander A | EVP and CCO | Feb 28, 2019 | Option Exercise | $5.51 | 4,544 | 25,037 | 14,161 | Mar 01, 2019, 05:18 PM |
MAIN ALAN J | EVP, Commercial Supply Ops | Feb 28, 2019 | Option Exercise | $5.51 | 6,885 | 37,936 | 67,067 | Mar 01, 2019, 05:17 PM |
Lapuerta Pablo | EVP and CMO | Feb 28, 2019 | Option Exercise | $5.51 | 6,809 | 37,518 | 47,098 | Mar 01, 2019, 05:16 PM |
COATS LONNEL | President and CEO | Feb 28, 2019 | Option Exercise | $5.51 | 18,641 | 102,712 | 87,539 | Mar 01, 2019, 05:15 PM |
Invus Public Equities, L.P. | Director | Jun 28, 2018 | Buy | $12.45 | 57,724 | 718,935 | 3,516,214 | Jun 29, 2018, 04:23 PM |
Invus Public Equities, L.P. | Director | Jun 27, 2018 | Buy | $12.54 | 125,114 | 1,568,442 | 3,458,490 | Jun 29, 2018, 04:23 PM |
Invus Public Equities, L.P. | Director | Jun 25, 2018 | Buy | $12.95 | 228,264 | 2,955,083 | 3,333,376 | Jun 26, 2018, 05:32 PM |
Invus Public Equities, L.P. | Director | Jun 22, 2018 | Buy | $13.36 | 25,461 | 340,090 | 3,105,112 | Jun 26, 2018, 05:32 PM |
Invus Public Equities, L.P. | Director | Jun 21, 2018 | Buy | $13.27 | 51,600 | 684,613 | 3,079,651 | Jun 21, 2018, 05:55 PM |
Invus Public Equities, L.P. | Director | Jun 20, 2018 | Buy | $13.28 | 12,391 | 164,613 | 3,028,051 | Jun 21, 2018, 05:55 PM |
Invus Public Equities, L.P. | Director | Jun 19, 2018 | Buy | $13.45 | 8,982 | 120,819 | 3,015,660 | Jun 21, 2018, 05:55 PM |
Invus Public Equities, L.P. | Director | Jun 14, 2018 | Buy | $12.66 | 9,200 | 116,462 | 2,970,094 | Jun 18, 2018, 06:56 PM |
Invus Public Equities, L.P. | Director | Jun 18, 2018 | Buy | $13.06 | 36,584 | 477,937 | 3,006,678 | Jun 18, 2018, 06:56 PM |
Invus Public Equities, L.P. | Director | Jun 12, 2018 | Buy | $12.83 | 107,023 | 1,373,244 | 2,960,894 | Jun 12, 2018, 06:10 PM |
Invus Public Equities, L.P. | Director | Jun 11, 2018 | Buy | $12.75 | 98,626 | 1,257,452 | 2,853,871 | Jun 12, 2018, 06:10 PM |
Invus Public Equities, L.P. | Director | Jun 08, 2018 | Buy | $12.89 | 29,747 | 383,427 | 2,755,245 | Jun 12, 2018, 06:10 PM |
Tessmer James F | VP, Finance & Accounting | Jun 08, 2018 | Option Exercise | $10.15 | 10,000 | 101,500 | 35,643 | Jun 12, 2018, 04:37 PM |
Tessmer James F | VP, Finance & Accounting | Jun 08, 2018 | Sale | $12.91 | 10,000 | 129,076 | 25,643 | Jun 12, 2018, 04:37 PM |
Invus Public Equities, L.P. | Director | Jun 06, 2018 | Buy | $12.58 | 95,079 | 1,196,370 | 2,668,059 | Jun 07, 2018, 07:37 PM |
Invus Public Equities, L.P. | Director | Jun 05, 2018 | Buy | $12.45 | 173,121 | 2,156,187 | 2,572,980 | Jun 07, 2018, 07:37 PM |
Invus Public Equities, L.P. | Director | Jun 07, 2018 | Buy | $12.93 | 57,439 | 742,508 | 2,725,498 | Jun 07, 2018, 07:37 PM |
Invus Public Equities, L.P. | Director | Jun 04, 2018 | Buy | $12.24 | 121,803 | 1,490,576 | 2,399,859 | Jun 04, 2018, 05:31 PM |
Invus Public Equities, L.P. | Director | Jun 01, 2018 | Buy | $12.22 | 147,339 | 1,800,041 | 2,278,056 | Jun 04, 2018, 05:31 PM |
Invus Public Equities, L.P. | Director | May 31, 2018 | Buy | $11.62 | 147,339 | 1,712,050 | 2,130,717 | Jun 04, 2018, 05:31 PM |
Invus Public Equities, L.P. | Director | May 29, 2018 | Buy | $9.84 | 147,339 | 1,450,420 | 1,836,039 | May 30, 2018, 08:53 PM |
Invus Public Equities, L.P. | Director | May 25, 2018 | Buy | $9.62 | 138,700 | 1,334,974 | 1,688,700 | May 30, 2018, 08:53 PM |
Invus Public Equities, L.P. | Director | May 30, 2018 | Buy | $10.32 | 147,339 | 1,521,025 | 1,983,378 | May 30, 2018, 08:53 PM |
Santini Alexander A | EVP and CCO | May 23, 2018 | Buy | $9.78 | 745 | 7,286 | 5,297 | May 25, 2018, 04:43 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2018 | Option Exercise | $8.53 | 6,133 | 52,314 | 59,492 | Mar 02, 2018, 05:12 PM |
TYLE PRAVEEN | EVP, R&D | Feb 28, 2018 | Option Exercise | $8.53 | 728 | 6,210 | 2,262 | Mar 02, 2018, 05:11 PM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2018 | Option Exercise | $8.53 | 1,805 | 15,397 | 25,643 | Mar 02, 2018, 05:11 PM |
Santini Alexander A | EVP and CCO | Feb 28, 2018 | Option Exercise | $8.53 | 1,652 | 14,092 | 4,552 | Mar 02, 2018, 05:09 PM |
MAIN ALAN J | EVP, Commercial Supply Ops | Feb 28, 2018 | Option Exercise | $8.53 | 4,962 | 42,326 | 53,801 | Mar 02, 2018, 05:08 PM |
Lapuerta Pablo | EVP and CMO | Feb 28, 2018 | Option Exercise | $8.53 | 4,822 | 41,132 | 33,975 | Mar 02, 2018, 05:08 PM |
COATS LONNEL | President and CEO | Feb 28, 2018 | Option Exercise | $8.53 | 9,494 | 80,984 | 58,079 | Mar 02, 2018, 05:07 PM |
Invus Public Equities, L.P. | Director | Nov 15, 2017 | Buy | $10.21 | 130,727 | 1,334,396 | 1,500,000 | Nov 17, 2017, 08:09 PM |
Invus Public Equities, L.P. | Director | Nov 17, 2017 | Buy | $9.85 | 50,000 | 492,500 | 1,550,000 | Nov 17, 2017, 08:09 PM |
COATS LONNEL | President and CEO | Nov 15, 2017 | Buy | $9.91 | 10,000 | 99,100 | 42,985 | Nov 15, 2017, 05:15 PM |
Invus Public Equities, L.P. | Director | Nov 14, 2017 | Buy | $9.47 | 215,133 | 2,037,847 | 1,369,273 | Nov 14, 2017, 07:32 PM |
Invus Public Equities, L.P. | Director | Nov 13, 2017 | Buy | $9.75 | 215,133 | 2,097,934 | 1,154,140 | Nov 14, 2017, 07:32 PM |
Invus Public Equities, L.P. | Director | Nov 10, 2017 | Buy | $9.74 | 145,680 | 1,418,384 | 939,007 | Nov 14, 2017, 07:32 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Nov 14, 2017 | Buy | $9.48 | 2,000 | 18,962 | 50,597 | Nov 14, 2017, 06:55 PM |
COATS LONNEL | President and CEO | Sep 15, 2017 | Buy | $12.54 | 30,000 | 376,337 | 32,985 | Sep 18, 2017, 06:40 AM |
BARKER SAM L | Director | Sep 15, 2017 | Buy | $12.50 | 1,000 | 12,500 | 25,623 | Sep 18, 2017, 06:36 AM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2017 | Option Exercise | $16.45 | 2,790 | 45,896 | 20,095 | Mar 01, 2017, 06:53 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2017 | Option Exercise | $16.45 | 6,455 | 106,185 | 48,597 | Mar 01, 2017, 06:52 PM |
Santini Alexander A | EVP and CCO | Feb 28, 2017 | Option Exercise | $16.45 | 1,093 | 17,980 | 1,259 | Mar 01, 2017, 06:51 PM |
MAIN ALAN J | EVP, CMC and Supply Operations | Feb 28, 2017 | Option Exercise | $16.45 | 5,361 | 88,188 | 44,230 | Mar 01, 2017, 06:50 PM |
Lapuerta Pablo | EVP and CMO | Feb 28, 2017 | Option Exercise | $16.45 | 5,252 | 86,395 | 24,613 | Mar 01, 2017, 06:49 PM |
COATS LONNEL | President and CEO | Feb 28, 2017 | Option Exercise | $16.45 | 5,258 | 86,494 | 20,767 | Mar 01, 2017, 06:48 PM |
Tessmer James F | VP, Finance & Accounting | Jun 06, 2016 | Option Exercise | $6.23 | 1,500 | 9,345 | 17,446 | Jun 08, 2016, 08:22 AM |
Tessmer James F | VP, Finance & Accounting | Jun 06, 2016 | Sale | $15.00 | 1,500 | 22,500 | 15,946 | Jun 08, 2016, 08:22 AM |
Tessmer James F | VP, Finance & Accounting | May 23, 2016 | Option Exercise | $6.23 | 6,000 | 37,380 | 21,946 | May 23, 2016, 05:56 PM |
Tessmer James F | VP, Finance & Accounting | May 23, 2016 | Sale | $13.00 | 6,000 | 78,000 | 15,946 | May 23, 2016, 05:56 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 29, 2016 | Option Exercise | $9.07 | 3,815 | 34,602 | 39,393 | Mar 02, 2016, 08:46 AM |
MAIN ALAN J | EVP, CMC and Supply Operations | Feb 29, 2016 | Option Exercise | $9.07 | 4,754 | 43,119 | 35,200 | Mar 02, 2016, 08:46 AM |
Lapuerta Pablo | EVP and CMO | Feb 29, 2016 | Option Exercise | $9.07 | 4,357 | 39,518 | 15,766 | Mar 02, 2016, 08:45 AM |
COATS LONNEL | President and CEO | Feb 29, 2016 | Option Exercise | $9.07 | 4,036 | 36,607 | 6,799 | Mar 02, 2016, 08:44 AM |
Tessmer James F | VP, Finance & Accounting | Feb 29, 2016 | Option Exercise | $9.07 | 1,626 | 14,748 | 15,946 | Mar 02, 2016, 08:43 AM |
Lapuerta Pablo | EVP and CMO | Mar 02, 2015 | Option Exercise | $0.94 | 18,266 | 17,170 | 58,767 | Mar 03, 2015, 04:11 PM |
MAIN ALAN J | EVP, CMC and Supply Operations | Mar 02, 2015 | Option Exercise | $0.94 | 25,318 | 23,799 | 190,032 | Mar 03, 2015, 04:10 PM |
NORTHCOTT JOHN | VP, Marketing, Comm Strategy | Mar 02, 2015 | Option Exercise | $0.94 | 3,015 | 2,834 | 8,235 | Mar 03, 2015, 04:08 PM |
Tessmer James F | VP, Finance & Accounting | Mar 02, 2015 | Option Exercise | $0.94 | 9,041 | 8,499 | 82,225 | Mar 03, 2015, 04:06 PM |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Mar 02, 2015 | Option Exercise | $0.94 | 20,718 | 19,475 | 204,821 | Mar 03, 2015, 04:04 PM |
Invus C.V. | Director | Dec 12, 2014 | Buy | $0.88 | 150,000 | 132,030 | 30,248,505 | Dec 12, 2014, 07:02 PM |
Invus C.V. | Director | Dec 10, 2014 | Buy | $0.90 | 315,896 | 285,349 | 30,098,505 | Dec 10, 2014, 09:14 PM |
Artal International S.C.A. | Director | Nov 26, 2014 | Buy | $1.00 | 149,253,731 | 149,999,999 | 149,253,731 | Nov 26, 2014, 07:19 PM |
SANDS ARTHUR T | President & CEO | Feb 28, 2014 | Option Exercise | $1.92 | 29,791 | 57,199 | 1,021,329 | Mar 03, 2014, 06:20 PM |
Lapuerta Pablo | EVP, Clin Dev and CMO | Feb 28, 2014 | Option Exercise | $1.92 | 11,992 | 23,025 | 26,783 | Mar 03, 2014, 06:19 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Feb 28, 2014 | Option Exercise | $1.92 | 18,668 | 35,843 | 146,350 | Mar 03, 2014, 06:18 PM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2014 | Option Exercise | $1.92 | 6,612 | 12,695 | 61,641 | Mar 03, 2014, 06:17 PM |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | Feb 28, 2014 | Option Exercise | $1.92 | 18,186 | 34,917 | 278,703 | Mar 03, 2014, 06:16 PM |
WADE JEFFREY L | EVP, Corp Dev and CFO | Feb 28, 2014 | Option Exercise | $1.92 | 16,297 | 31,290 | 149,789 | Mar 03, 2014, 06:15 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Feb 28, 2013 | Option Exercise | $1.98 | 12,572 | 24,893 | 114,768 | Mar 01, 2013, 05:30 PM |
Lapuerta Pablo | EVP, Clin Dev and CMO | Feb 28, 2013 | Option Exercise | $1.98 | 4,725 | 9,356 | 8,275 | Mar 01, 2013, 05:29 PM |
SANDS ARTHUR T | President & CEO | Feb 28, 2013 | Option Exercise | $1.98 | 20,034 | 39,667 | 942,870 | Mar 01, 2013, 05:27 PM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2013 | Option Exercise | $1.98 | 3,807 | 7,538 | 48,003 | Mar 01, 2013, 05:26 PM |
WADE JEFFREY L | EVP, Corp Dev and CFO | Feb 28, 2013 | Option Exercise | $1.98 | 10,461 | 20,713 | 110,836 | Mar 01, 2013, 05:24 PM |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | Feb 28, 2013 | Option Exercise | $1.98 | 11,692 | 23,150 | 234,139 | Mar 01, 2013, 05:22 PM |
WADE JEFFREY L | EVP, Corp Dev and CFO | Jan 31, 2013 | Option Exercise | $2.11 | 10,317 | 21,769 | 83,047 | Feb 04, 2013, 05:04 PM |
SANDS ARTHUR T | President & CEO | Jan 31, 2013 | Option Exercise | $2.11 | 21,434 | 45,226 | 889,654 | Feb 04, 2013, 05:02 PM |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | Jan 31, 2013 | Option Exercise | $2.11 | 13,499 | 28,483 | 203,081 | Feb 04, 2013, 05:00 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Jan 31, 2013 | Option Exercise | $2.11 | 12,537 | 26,453 | 93,590 | Feb 04, 2013, 04:58 PM |
Tessmer James F | VP, Finance & Accounting | Jan 31, 2013 | Option Exercise | $2.11 | 4,310 | 9,094 | 37,560 | Feb 04, 2013, 04:56 PM |
Invus, CV | Director | Oct 23, 2012 | Buy | $2.25 | 3,000,000 | 6,750,000 | 283,154,744 | Oct 25, 2012, 05:21 PM |
Artal International S.C.A. | Director | Oct 23, 2012 | Buy | $2.25 | 3,000,000 | 6,750,000 | 283,154,744 | Oct 25, 2012, 05:21 PM |
Tessmer James F | VP, Finance & Accounting | Feb 28, 2012 | Option Exercise | $1.78 | 2,299 | 4,092 | 28,670 | Mar 01, 2012, 04:07 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Feb 28, 2012 | Option Exercise | $1.78 | 5,907 | 10,514 | 58,277 | Mar 01, 2012, 04:07 PM |
WADE JEFFREY L | EVP, Corp Dev and CFO | Feb 28, 2012 | Option Exercise | $1.78 | 4,959 | 8,827 | 61,764 | Mar 01, 2012, 04:06 PM |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | Feb 28, 2012 | Option Exercise | $1.78 | 5,621 | 10,005 | 174,480 | Mar 01, 2012, 04:05 PM |
SANDS ARTHUR T | President & CEO | Feb 28, 2012 | Option Exercise | $1.78 | 9,588 | 17,067 | 837,388 | Mar 01, 2012, 04:04 PM |
Ulys, LLC | Director | Dec 22, 2011 | Option Exercise | $1.13 | 115,004,247 | 129,954,799 | 250,372,135 | Dec 27, 2011, 05:26 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Dec 22, 2011 | Option Exercise | $1.13 | 19,211 | 21,708 | 64,184 | Dec 27, 2011, 04:12 PM |
BARKER SAM L | Director | Dec 22, 2011 | Option Exercise | $1.13 | 34,000 | 38,420 | 100,000 | Dec 27, 2011, 04:12 PM |
SANDS ARTHUR T | President & CEO | Dec 22, 2011 | Option Exercise | $1.13 | 25,000 | 28,250 | 810,726 | Dec 27, 2011, 04:10 PM |
MAIN ALAN J | EVP, Pharmaceutical Research | Feb 23, 2011 | Option Exercise | $1.81 | 5,926 | 10,726 | 44,973 | Feb 25, 2011, 04:41 PM |
Tessmer James F | VP, Finance & Accounting | Feb 23, 2011 | Option Exercise | $1.81 | 2,116 | 3,830 | 23,469 | Feb 25, 2011, 04:40 PM |
SANDS ARTHUR T | President & CEO | Feb 23, 2011 | Option Exercise | $1.81 | 10,464 | 18,940 | 785,726 | Feb 25, 2011, 04:38 PM |
WADE JEFFREY L | EVP, Corp Dev and CFO | Feb 23, 2011 | Option Exercise | $1.81 | 5,926 | 10,726 | 47,973 | Feb 25, 2011, 04:37 PM |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | Feb 23, 2011 | Option Exercise | $1.81 | 7,881 | 14,265 | 158,851 | Feb 25, 2011, 04:35 PM |
Owner | Relationship | Date | Value($) |
Artal International S.C.A. | Director | 03/13/2024 | 124,875,037 |
Alexander Kristen | VP, Finance and Accounting | 02/28/2024 | 30,898 |
WADE JEFFREY L | President and CFO | 02/28/2024 | 98,750 |
McDermott Wendy | VP, Human Resources | 02/28/2024 | 58,753 |
MAIN ALAN J | EVP, Innov & Chem Sciences | 02/28/2024 | 63,949 |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | 02/28/2024 | 63,805 |
Granowitz Craig B | SVP, Chief Medical Officer | 02/28/2024 | 81,914 |
Crum Brian T | SVP, General Counsel & Secr. | 02/28/2024 | 67,082 |
COATS LONNEL | Chief Executive Officer | 02/28/2024 | 160,792 |
COATS LONNEL | Chief Executive Officer | 11/16/2023 | 94,797 |
Amouyal Philippe | Director | 11/13/2023 | 201,520 |
COATS LONNEL | Chief Executive Officer | 11/10/2023 | 10,100 |
DEBBANE RAYMOND | Director | 10/12/2023 | 153,805 |
DEBBANE RAYMOND | Director | 10/11/2023 | 370,784 |
DEBBANE RAYMOND | Director | 10/10/2023 | 579,367 |
WADE JEFFREY L | President and CFO | 09/14/2023 | 13,800 |
McDermott Wendy | VP, Human Resources | 08/04/2023 | 11,040 |
COATS LONNEL | Chief Executive Officer | 06/29/2023 | 21,600 |
McDermott Wendy | VP, Human Resources | 06/23/2023 | 24,300 |
COATS LONNEL | Chief Executive Officer | 06/26/2023 | 21,792 |
COATS LONNEL | Chief Executive Officer | 06/23/2023 | 24,950 |
COATS LONNEL | Chief Executive Officer | 06/22/2023 | 92,400 |
WADE JEFFREY L | President and CFO | 06/20/2023 | 28,000 |
Artal International S.C.A. | Director | 06/05/2023 | 72,215,127 |
Alexander Kristen | VP, Finance and Accounting | 02/28/2023 | 11,566 |
Seth Kiernan | VP, Chief Commercial Officer | 02/28/2023 | 25,634 |
McDermott Wendy | VP, Human Resources | 02/28/2023 | 14,029 |
MAIN ALAN J | EVP, Innov & Chem Sciences | 02/28/2023 | 45,453 |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | 02/28/2023 | 41,486 |
Granowitz Craig B | SVP, Chief Medical Officer | 02/28/2023 | 27,628 |
Crum Brian T | SVP, General Counsel & Secr. | 02/28/2023 | 44,565 |
WADE JEFFREY L | President and CFO | 02/28/2023 | 65,653 |
COATS LONNEL | Chief Executive Officer | 02/28/2023 | 110,607 |
Invus US Partners LLC | Director | 08/05/2022 | 368,475 |
Artal International S.C.A. | Director | 08/05/2022 | 6,065,175 |
Artal International S.C.A. | Director | 08/01/2022 | 40,434,500 |
Invus US Partners LLC | Director | 08/01/2022 | 2,456,500 |
DEBBANE RAYMOND | Director | 08/01/2022 | 2,456,500 |
Alexander Kristen | VP, Finance and Accounting | 02/28/2022 | 9,510 |
Seth Kiernan | VP, Chief Commercial Officer | 02/28/2022 | 23,544 |
MAIN ALAN J | EVP, Innov & Chem Sciences | 02/28/2022 | 56,305 |
Kassler-Taub Kenneth B. | SVP, Regulatory & QA | 02/28/2022 | 37,737 |
Crum Brian T | SVP, General Counsel & Secr. | 02/28/2022 | 42,918 |
WADE JEFFREY L | President and CFO | 02/28/2022 | 73,453 |
COATS LONNEL | Chief Executive Officer | 02/28/2022 | 136,951 |
Tessmer James F | VP, Finance & Accounting | 03/15/2021 | 39,720 |
Tessmer James F | VP, Finance & Accounting | 03/15/2021 | 158,440 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/28/2021 | 191,139 |
TYLE PRAVEEN | EVP, R&D | 02/28/2021 | 119,066 |
Crum Brian T | VP, General Counsel & Secr. | 02/28/2021 | 106,843 |
MAIN ALAN J | EVP, Innov & Chem Sciences | 02/28/2021 | 146,769 |
COATS LONNEL | President and CEO | 02/28/2021 | 395,723 |
Tessmer James F | VP, Finance & Accounting | 02/28/2021 | 77,400 |
Artal International S.C.A. | Director | 12/16/2020 | 35,000,001 |
Invus Public Equities, L.P. | Director | 12/16/2020 | 35,000,001 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 04/22/2020 | 18,916 |
TYLE PRAVEEN | EVP, R&D | 04/22/2020 | 9,494 |
Tessmer James F | VP, Finance & Accounting | 04/22/2020 | 7,834 |
Santini Alexander A | EVP and CCO | 04/22/2020 | 13,353 |
MAIN ALAN J | EVP, Commercial Supply Ops | 04/22/2020 | 13,353 |
Crum Brian T | VP, General Counsel & Secr. | 04/22/2020 | 12,540 |
Lapuerta Pablo | EVP and CMO | 04/22/2020 | 13,353 |
Santini Alexander A | EVP and CCO | 02/28/2020 | 34,403 |
Lapuerta Pablo | EVP and CMO | 02/28/2020 | 36,855 |
MAIN ALAN J | EVP, Commercial Supply Ops | 02/28/2020 | 35,342 |
Crum Brian T | VP, General Counsel & Secr. | 02/28/2020 | 19,224 |
COATS LONNEL | President and CEO | 02/28/2020 | 125,536 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/28/2020 | 44,389 |
Tessmer James F | VP, Finance & Accounting | 02/28/2020 | 10,809 |
COATS LONNEL | President and CEO | 09/18/2019 | 155,000 |
Santini Alexander A | EVP and CCO | 09/18/2019 | 15,115 |
COATS LONNEL | President and CEO | 09/17/2019 | 156,403 |
DEBBANE RAYMOND | Director | 09/16/2019 | 254,785 |
DEBBANE RAYMOND | Director | 09/13/2019 | 22,806 |
DEBBANE RAYMOND | Director | 09/13/2019 | 474,760 |
SOBECKI CHRISTOPHER J | Director | 09/16/2019 | 63,718 |
SOBECKI CHRISTOPHER J | Director | 09/13/2019 | 238,750 |
COATS LONNEL | President and CEO | 08/19/2019 | 4,194 |
COATS LONNEL | President and CEO | 08/16/2019 | 49,835 |
Tessmer James F | VP, Finance & Accounting | 08/02/2019 | 11,400 |
BARKER SAM L | Director | 08/02/2019 | 28,200 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/28/2019 | 47,601 |
Tessmer James F | VP, Finance & Accounting | 02/28/2019 | 13,781 |
Santini Alexander A | EVP and CCO | 02/28/2019 | 25,037 |
MAIN ALAN J | EVP, Commercial Supply Ops | 02/28/2019 | 37,936 |
Lapuerta Pablo | EVP and CMO | 02/28/2019 | 37,518 |
COATS LONNEL | President and CEO | 02/28/2019 | 102,712 |
Invus Public Equities, L.P. | Director | 06/28/2018 | 718,935 |
Invus Public Equities, L.P. | Director | 06/27/2018 | 1,568,442 |
Invus Public Equities, L.P. | Director | 06/25/2018 | 2,955,083 |
Invus Public Equities, L.P. | Director | 06/22/2018 | 340,090 |
Invus Public Equities, L.P. | Director | 06/21/2018 | 684,613 |
Invus Public Equities, L.P. | Director | 06/20/2018 | 164,613 |
Invus Public Equities, L.P. | Director | 06/19/2018 | 120,819 |
Invus Public Equities, L.P. | Director | 06/14/2018 | 116,462 |
Invus Public Equities, L.P. | Director | 06/18/2018 | 477,937 |
Invus Public Equities, L.P. | Director | 06/12/2018 | 1,373,244 |
Invus Public Equities, L.P. | Director | 06/11/2018 | 1,257,452 |
Invus Public Equities, L.P. | Director | 06/08/2018 | 383,427 |
Tessmer James F | VP, Finance & Accounting | 06/08/2018 | 101,500 |
Tessmer James F | VP, Finance & Accounting | 06/08/2018 | 129,076 |
Invus Public Equities, L.P. | Director | 06/06/2018 | 1,196,370 |
Invus Public Equities, L.P. | Director | 06/05/2018 | 2,156,187 |
Invus Public Equities, L.P. | Director | 06/07/2018 | 742,508 |
Invus Public Equities, L.P. | Director | 06/04/2018 | 1,490,576 |
Invus Public Equities, L.P. | Director | 06/01/2018 | 1,800,041 |
Invus Public Equities, L.P. | Director | 05/31/2018 | 1,712,050 |
Invus Public Equities, L.P. | Director | 05/29/2018 | 1,450,420 |
Invus Public Equities, L.P. | Director | 05/25/2018 | 1,334,974 |
Invus Public Equities, L.P. | Director | 05/30/2018 | 1,521,025 |
Santini Alexander A | EVP and CCO | 05/23/2018 | 7,286 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/28/2018 | 52,314 |
TYLE PRAVEEN | EVP, R&D | 02/28/2018 | 6,210 |
Tessmer James F | VP, Finance & Accounting | 02/28/2018 | 15,397 |
Santini Alexander A | EVP and CCO | 02/28/2018 | 14,092 |
MAIN ALAN J | EVP, Commercial Supply Ops | 02/28/2018 | 42,326 |
Lapuerta Pablo | EVP and CMO | 02/28/2018 | 41,132 |
COATS LONNEL | President and CEO | 02/28/2018 | 80,984 |
Invus Public Equities, L.P. | Director | 11/15/2017 | 1,334,396 |
Invus Public Equities, L.P. | Director | 11/17/2017 | 492,500 |
COATS LONNEL | President and CEO | 11/15/2017 | 99,100 |
Invus Public Equities, L.P. | Director | 11/14/2017 | 2,037,847 |
Invus Public Equities, L.P. | Director | 11/13/2017 | 2,097,934 |
Invus Public Equities, L.P. | Director | 11/10/2017 | 1,418,384 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 11/14/2017 | 18,962 |
COATS LONNEL | President and CEO | 09/15/2017 | 376,337 |
BARKER SAM L | Director | 09/15/2017 | 12,500 |
Tessmer James F | VP, Finance & Accounting | 02/28/2017 | 45,896 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/28/2017 | 106,185 |
Santini Alexander A | EVP and CCO | 02/28/2017 | 17,980 |
MAIN ALAN J | EVP, CMC and Supply Operations | 02/28/2017 | 88,188 |
Lapuerta Pablo | EVP and CMO | 02/28/2017 | 86,395 |
COATS LONNEL | President and CEO | 02/28/2017 | 86,494 |
Tessmer James F | VP, Finance & Accounting | 06/06/2016 | 9,345 |
Tessmer James F | VP, Finance & Accounting | 06/06/2016 | 22,500 |
Tessmer James F | VP, Finance & Accounting | 05/23/2016 | 37,380 |
Tessmer James F | VP, Finance & Accounting | 05/23/2016 | 78,000 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 02/29/2016 | 34,602 |
MAIN ALAN J | EVP, CMC and Supply Operations | 02/29/2016 | 43,119 |
Lapuerta Pablo | EVP and CMO | 02/29/2016 | 39,518 |
COATS LONNEL | President and CEO | 02/29/2016 | 36,607 |
Tessmer James F | VP, Finance & Accounting | 02/29/2016 | 14,748 |
Lapuerta Pablo | EVP and CMO | 03/02/2015 | 17,170 |
MAIN ALAN J | EVP, CMC and Supply Operations | 03/02/2015 | 23,799 |
NORTHCOTT JOHN | VP, Marketing, Comm Strategy | 03/02/2015 | 2,834 |
Tessmer James F | VP, Finance & Accounting | 03/02/2015 | 8,499 |
WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | 03/02/2015 | 19,475 |
Invus C.V. | Director | 12/12/2014 | 132,030 |
Invus C.V. | Director | 12/10/2014 | 285,349 |
Artal International S.C.A. | Director | 11/26/2014 | 149,999,999 |
SANDS ARTHUR T | President & CEO | 02/28/2014 | 57,199 |
Lapuerta Pablo | EVP, Clin Dev and CMO | 02/28/2014 | 23,025 |
MAIN ALAN J | EVP, Pharmaceutical Research | 02/28/2014 | 35,843 |
Tessmer James F | VP, Finance & Accounting | 02/28/2014 | 12,695 |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | 02/28/2014 | 34,917 |
WADE JEFFREY L | EVP, Corp Dev and CFO | 02/28/2014 | 31,290 |
MAIN ALAN J | EVP, Pharmaceutical Research | 02/28/2013 | 24,893 |
Lapuerta Pablo | EVP, Clin Dev and CMO | 02/28/2013 | 9,356 |
SANDS ARTHUR T | President & CEO | 02/28/2013 | 39,667 |
Tessmer James F | VP, Finance & Accounting | 02/28/2013 | 7,538 |
WADE JEFFREY L | EVP, Corp Dev and CFO | 02/28/2013 | 20,713 |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | 02/28/2013 | 23,150 |
WADE JEFFREY L | EVP, Corp Dev and CFO | 01/31/2013 | 21,769 |
SANDS ARTHUR T | President & CEO | 01/31/2013 | 45,226 |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | 01/31/2013 | 28,483 |
MAIN ALAN J | EVP, Pharmaceutical Research | 01/31/2013 | 26,453 |
Tessmer James F | VP, Finance & Accounting | 01/31/2013 | 9,094 |
Invus, CV | Director | 10/23/2012 | 6,750,000 |
Artal International S.C.A. | Director | 10/23/2012 | 6,750,000 |
Tessmer James F | VP, Finance & Accounting | 02/28/2012 | 4,092 |
MAIN ALAN J | EVP, Pharmaceutical Research | 02/28/2012 | 10,514 |
WADE JEFFREY L | EVP, Corp Dev and CFO | 02/28/2012 | 8,827 |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | 02/28/2012 | 10,005 |
SANDS ARTHUR T | President & CEO | 02/28/2012 | 17,067 |
Ulys, LLC | Director | 12/22/2011 | 129,954,799 |
MAIN ALAN J | EVP, Pharmaceutical Research | 12/22/2011 | 21,708 |
BARKER SAM L | Director | 12/22/2011 | 38,420 |
SANDS ARTHUR T | President & CEO | 12/22/2011 | 28,250 |
MAIN ALAN J | EVP, Pharmaceutical Research | 02/23/2011 | 10,726 |
Tessmer James F | VP, Finance & Accounting | 02/23/2011 | 3,830 |
SANDS ARTHUR T | President & CEO | 02/23/2011 | 18,940 |
WADE JEFFREY L | EVP, Corp Dev and CFO | 02/23/2011 | 10,726 |
ZAMBROWICZ BRIAN P | EVP, Chief Scientific Officer | 02/23/2011 | 14,265 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 7,005,153 | 0.00027% | 5.26% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 2,348,916 | 0.00038% | 10.48% | Other |
D. E. SHAW & CO., INC. | 359,210 | 0.00048% | -54.19% | Other |
FISHER ASSET MANAGEMENT, LLC | 523,394 | 0.00066% | Exited | Other |
RENAISSANCE TECHNOLOGIES LLC | 412,175 | 0.00098% | 51.39% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 103,144 | 0.00291% | New | Other |
TUDOR INVESTMENT CORP ET AL | 47,101 | 0.00058% | No change | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 29,558 | 0.00007% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View